Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Chronic inducible urticaria
What has stayed the same, what has changed?
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- Glomerulonephritis: IgA nephropathy
Pathogenesis-based and nephroprotective therapeutic approaches
- Case report: Acute rheumatic fever
ARF with myocarditis and occlusion of the RCA
- Internal thoracoscopy
Diagnostic indications
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Follow-up care for head and neck cancer